dean-effectsof-2012.pdf (46.75 kB)
Effects of N-acetyl cysteine on cognitive function in bipolar disorder
journal contribution
posted on 2012-10-01, 00:00 authored by Olivia DeanOlivia Dean, A Bush, D Copolov, K Kohlmann, S Jeavons, I Schapkaitz, Murray Anderson-Hunt, Michael BerkMichael BerkAims
Bipolar disorder is characterized by progressive changes in cognition with declines in executive functioning, memory and sustained attention. Current pharmacotherapies for bipolar disorder target mood symptoms but have not addressed these cognitive changes resulting in euthymic individuals who still experience cognitive deficits. N-acetyl cysteine (NAC) has been shown to have effects on antioxidant status, glutamate transmission, inflammation and neurogenesis. Adjunctive treatment with NAC improves the symptoms experienced by those with bipolar disorder, particularly depression, and it was hypothesized that cognition may also be improved following NAC treatment.
Methods
As part of a larger randomized, double-blind, placebo-controlled trial, participants in the current report were tested at baseline and 6 months to assess changes in cognitive function following either 2000 mg of NAC daily or placebo.
Results
This study failed to find changes in cognitive function following treatment with NAC compared to placebo.
Conclusions
While an important pilot study, this study had a small sample size and included a limited battery of cognitive tests. Further investigations on the effects of NAC on cognitive performance in bipolar disorder are required.
Bipolar disorder is characterized by progressive changes in cognition with declines in executive functioning, memory and sustained attention. Current pharmacotherapies for bipolar disorder target mood symptoms but have not addressed these cognitive changes resulting in euthymic individuals who still experience cognitive deficits. N-acetyl cysteine (NAC) has been shown to have effects on antioxidant status, glutamate transmission, inflammation and neurogenesis. Adjunctive treatment with NAC improves the symptoms experienced by those with bipolar disorder, particularly depression, and it was hypothesized that cognition may also be improved following NAC treatment.
Methods
As part of a larger randomized, double-blind, placebo-controlled trial, participants in the current report were tested at baseline and 6 months to assess changes in cognitive function following either 2000 mg of NAC daily or placebo.
Results
This study failed to find changes in cognitive function following treatment with NAC compared to placebo.
Conclusions
While an important pilot study, this study had a small sample size and included a limited battery of cognitive tests. Further investigations on the effects of NAC on cognitive performance in bipolar disorder are required.
History
Journal
Psychiatry and clinical neurosciencesVolume
66Issue
6Pagination
514 - 517Publisher
Wiley-Blackwell Publishing AsiaLocation
Richmond, Vic.Publisher DOI
ISSN
1323-1316eISSN
1440-1819Language
engPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2012, Wiley-Blackwell PublishingUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC